More articles from Volume 47, Issue 3, 2018
Clinical manifestation in patients with ischemic stroke in the border zone of the middle cerebral artery
Suicide as a cause of death with drug addicts
Microanatomical characteristics of arterial vascularization of the intracranial segment of optic nerve
Dry eye disease incidence in hemodialysis
Prevalence of anti HCV antibodies and anti HBV antibodies is risk groups of patients
The most frequent comorbidities at patients with the chronic obstructive pulmonary disease
,
Biljana Krdžić
,
Jelena Milovanović
,
Maja Šipić
,
Zlatica Petković
Biserka Nedeljković
Abstract
References
1.
World Health Organization: World Health Statistic. 2008.
2.
Global Strategy for the Diagnosis, Menagment and Prevention of COPD. In.
3.
Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje hronične opstruktivne bolesti pluća. 2013.
4.
Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Vol. 63, Thorax. 2008. p. 487–92.
5.
Moitra S, Puri R, Paul D, Huang YCT. Global perspectives of emerging occupational and environmental lung diseases. Vol. 21, Current Opinion in Pulmonary Medicine. 2015. p. 114–20.
6.
European Lung Function, COPD Burden in Europe.
7.
Clarenbach CF, Senn O, Sievi NA, Camen G, van Gestel AJR, Rossi VA, et al. Determinants of endothelial function in patients with COPD. Vol. 42, European Respiratory Journal. 2013. p. 1194–204.
8.
Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R. Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease. Vol. 59, Angiology. 2008. p. 357–64.
9.
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Vol. 33, European Respiratory Journal. 2009. p. 1165–85.
10.
MacCallum PK. Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers. Vol. 2, Proceedings of the American Thoracic Society. 2005. p. 34–43.
11.
Lopez AD. Chronic obstructive pulmonary disease: current burden and future projections. Vol. 27, European Respiratory Journal. 2006. p. 397–412.
12.
Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Vol. 32, European Respiratory Journal. p. 962–9.
13.
Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Cardiovascular events in patients with COPD: TORCH Study results. Vol. 65, Thorax. 2010. p. 719–25.
14.
Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Vol. 1, The Lancet Respiratory Medicine. 2013. p. 73–83.
15.
Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Vol. 31, European Respiratory Journal. 2008. p. 204–12.
16.
Clarenbach CF, Thurnheer R, Kohler M. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives. Vol. 6, Expert Review of Respiratory Medicine. 2012. p. 37–43.
17.
MacNee W, Maclay J, McAllister D. Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease. Vol. 5, Proceedings of the American Thoracic Society. 2008. p. 824–33.
18.
Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, et al. Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease. Vol. 178, American Journal of Respiratory and Critical Care Medicine. 2008. p. 1211–8.
19.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation. Vol. 23, Diabetic Medicine. 2006. p. 469–80.
20.
Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease. Vol. 80, Respiration. 2010. p. 112–9.
21.
Krdžić B, Milovanović J, Šipić M, Nedeljković B, Petkovic Z, Pajovic S. Hronična opstruktivna bolest pluća i komorbiditet diabetes mellitus,XVII Kongres Udruženja Internista Srbije sa međ.učeš. 2017.
22.
Baker EH. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Vol. 61, Thorax. 2006. p. 284–9.
23.
Küpeli E, Ulubay G, Ulasli SS, Sahin T, Erayman Z, Gürsoy A. Metabolic Syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Vol. 38, Endocrine. 2010. p. 76–82.
24.
Suissa S, Kezouh A, Ernst P. Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression. Vol. 123, The American Journal of Medicine. 2010. p. 1001–6.
25.
Wasswa-Kintu S. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Vol. 60, Thorax. 2005. p. 570–5.
26.
Mannino DM, Aguayo SM, Petty TL, Redd SC. Low Lung Function and Incident Lung Cancer in the United States. Vol. 163, Archives of Internal Medicine. 2003. p. 1475.
27.
COPD and Comorbidity. 2013.
28.
Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001. Vol. 128, Chest. 2005. p. 2005–11.
29.
Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Vol. 104, Respiratory Medicine. 2010. p. 1877–82.
30.
Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, et al. Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension. Vol. 54, Journal of the American College of Cardiology. 2009. p. S85–96.
31.
Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease. Vol. 189, Lung. 2011. p. 207–12.
32.
Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease. Vol. 189, Lung. 2011. p. 207–12.
33.
Fisher MR, Criner GJ, Fishman AP, Hassoun PM, Minai OA, Scharf SM, et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Vol. 30, European Respiratory Journal. 2007. p. 914–21.
34.
Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, et al. Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease. Vol. 170, American Journal of Respiratory and Critical Care Medicine. 2004. p. 1286–93.
35.
Bošnjak-Petrović V. Sistemske manifestacije hronične opstruktivne bolesti pluća.Keser D, Ljuca F i sar.Plućne bolesti,2013.
36.
Spitzer C, Gläser S, Grabe HJ, Ewert R, Barnow S, Felix SB, et al. Mental health problems, obstructive lung disease and lung function: Findings from the general population. Vol. 71, Journal of Psychosomatic Research. 2011. p. 174–9.
37.
Regvat J, Žmitek A, Vegnuti M, Košnik M, Šuškovič S. Anxiety and Depression during Hospital Treatment of Exacerbation of Chronic Obstructive Pulmonary Disease. Vol. 39, Journal of International Medical Research. 2011. p. 1028–38.
38.
Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and Depression in COPD. Vol. 134, Chest. 2008. p. 43S-56S.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
